AGIOS PHARMACEUTICALS, INC.: capex
| Value | {"amount": 13892000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-09-30 |
| Status | superseded |
| Entity | AGIOS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:11:26.786511+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1f3e3e19-515e-4827-9af8-f25dec45f8b1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001439222-20-000069Retrieved: 2026-08-19T14:11:26.786511+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001439222/capex/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1f3e3e19-515e-4827-9af8-f25dec45f8b1
History
- no predecessors — first report